Key sentence from the paper: “Evidence of increased emotional lability and depressed mood in men who receive ADT…and the risk of depression in the patient’s partner is discussed. The evidence for adverse cognitive effects with ADT is still emerging but suggests that ADT is associated with impairment in multiple cognitive domains.”
Read MoreIs intermittent ADT as effective as continuous ADT in treating prostate cancer?
Key sentence from the paper: “…[intermittent ADT] produces a longer duration in median time to [castrate resistant prostate cancer] than does [continuous ADT].”
Read MoreHow does ADT affect the cardiovascular system?
Key sentence from the paper: “Three months or longer exposure to androgen deprivation therapy was associated with reduced cardiorespiratory capacity and resting metabolic rate.”
Read MoreCould ADT ever be truly curative?
Key sentence from the paper: “In patients with high-risk prostate cancer, we observed 6 cases (5.4%) of pT0 disease that showed no tumor recurrence during the follow-up… ADT can induce a complete pathological response, and can potentially eradicate advanced prostate cancer.”
Read MoreHow helpful is the early chemotherapy combined with ADT?
Key sentence from the paper: “… docetaxel should be considered in routine practice for suitable men with newly diagnosed metastatic disease, and also for selected men with high-risk non-metastatic disease in view of substantial prolongation of [failure-free survival].”
Read MoreCould enzalutamide cause sleep apnea?
Key sentence from the paper: “…chronological arguments remain strongest for relating [sleep apnea] to enzalutamide.”
Read MoreWhat are the pros and cons of using enzalutamide (Xtandi) to treat advanced prostate cancer before or after chemo?
Key sentence from the paper: “31% of the chemotherapy-naïve patients remained on enzalutamide therapy for >2yr and 17% for >4%. This contrasts with the 2-yr on –treatment rate of 5% for postchemotherapy patients.”
Read MoreWhat are the pros and cons of using enzalutamide (Xtandi) for front line ADT?
Key sentence from the paper: “Long-term enzalutamide monotherapy in men with noncastrate [hormone naïve prostate cancer] is associated with large sustained reductions in PSA, signals indicating a favorable tumor response, and favorable safety/tolerability profile.”
Read MoreCan mood decline due to ADT affect relationship?
Key sentence from the paper: “[men] on ADT experienced greater bother at loss of sexual function than patients not on ADT, suggesting that loss of libido when on ADT does not mitigate the psychological distress associated with loss of erection.”
Read MoreIs ADT associated with a worse mood in patients and is that obvious to others?
Key sentence from the paper: “Both patients and partners report that patients have had significantly worse mood since beginning ADT. Partners reported a larger difference in the patients’ mood than did the patients themselves for all parameters [i.e., depression, anger, fatigue, confusion] except vigor and tension.”
Read More